Outcomes between patients who received either an in-person or telehealth ID consultation did not differ, according to a study from Duke University researchers published in Clinical Infectious Diseases.
Numerous studies have shown the benefits of ID consults, which can improve various outcomes — from reduced mortality to reduced hospital stays. The Duke analysis supports tele-ID consultations in the face of a nationwide shortage of ID physicians.
The study included 3,223 patients who had an ID consultation at Duke Regional Hospital or Duke Raleigh Hospital in North Carolina from 2022 to

The FDA announced the approval of the first size-adjustable pulmonary valve replacement designed for children with congenital heart disease.
The device (Autus Size-Adjustable Valve, Edwards Lifesciences) is designed to be expanded to keep pace with a child’s growth and could reduce the need for repeat surgeries, according to the FDA press release.
The valve can be surgically implanted as small as approximately 13 mm in diameter and can expand up to 22 mm via transcatheter balloon dilation, according to the release.
In addition, the FDA said this is the first approved heart valve designed

Communication of needs at home and in clinic to build a manageable work schedule is essential to balancing motherhood and a career as a surgeon, a speaker reported.
At the Women in Medicine Summit, Vaninder Dhillon, MD, associate professor in the department of otolaryngology, head and neck surgery at Johns Hopkins Medicine, highlighted the five points, or “truths for the surgeon-mom:”
Healio spoke with Dhillon, who is a mother of three children, about the balance of being a surgeon and a mother, the importance of communicating your needs in clinic and at home and advice for female

The FDA has granted 510(k) clearance to allow over-the-counter sale of a needle-free continuous glucose monitor, according to an industry press release.
Biolinq Shine (Biolinq Inc.) is a CGM that uses microsensors that sit close to the user’s skin, allowing the sensor to be placed on the forearm without the use of a needle. The CGM is intended for use by adults aged 22 years and older who do not use insulin.
Biolinq Shine includes a color-coded LED screen to display real-time glucose and signal to the user whether their levels are at, below or above range. The device gathers glucose, physical

GLP-1 receptor agonist users experienced higher rates of nail disorders and hair loss than those with no exposure to the medication, according to a presentation at the European Academy of Dermatology and Venerology Congress.
While the association of hair loss with GLP-1s has been increasingly outlined in studies, the evidence suggesting a link with nail disorders is new, according to Charles Taïeb, MD, executive master in health policy at Sciences Po in Paris.
“Until now, nail changes associated with the use of GLP-1 receptor agonists had essentially been anecdotal and isolated to a handful of

Researchers developed and validated a new classification system that may standardize reporting of all relevant grades of clinical presentation and management of surgical site outcomes, according to published results.
To develop a classification system for dehiscence, inflammation/infection, seroma and hematoma (DISH) that would apply across multiple medical specialties, Giles Bond-Smith, MBBS, BSc, FRCS, a consultant liver, pancreatic and biliary, abdominal wall reconstruction and emergency surgeon at Oxford University Hospitals NHS Foundation Trust, and colleagues performed a systematic

Editor’s note: This is a developing story. Please check back soon for updates.
SpyGlass Pharma announced the acquisition of Advanced Vision Science in an effort to boost its IOL manufacturing capacity, according to a press release.
SpyGlass acquired all outstanding stock of Advanced Vision Science (AVS) for $13 million in cash.
AVS was a subsidiary of Santen Pharmaceutical and is the current supplier of IOLs for Spyglass at it develops the bimatoprost drug pad-IOL, or BIM-IOL, system, which is under investigation in two phase 3 trials, according to the release.
As part of the deal, AVS will

Ultraprocessed animal- and plant-based foods were associated with greater risks for developing chronic kidney disease among older adults, according to data published in the Clinical Journal of the American Society of Nephrology.
Previous studies have linked plant-based choices to preserved kidney function and a lower risk for developing CKD, according to Hyunju Kim, PhD, MPH, assistant professor in the department of epidemiology at University of Washington, Seattle, and colleagues. However, highly processed plant-based products may not provide the same health benefits as minimally processed

An investigational amylin receptor agonist combined with tirzepatide induced weight loss of up to 23.3% for adults with type 2 diabetes and obesity, according to data from a phase 2 2 trial.
As Healio previously reported at ObesityWeek in 2025, eloralintide (Eli Lilly), a once-weekly injectable medication, was linked to weight loss of up to 19.9% for adults with overweight or obesity without diabetes in a phase 2 trial. In new findings presented at the European Association for the Study of Diabetes annual meeting, researchers unveiled data that showed combining eloralintide with the

Early intervention may mitigate elevated risk for cancer-specific mortality observed among people with pre-existing depression, according to retrospective findings.
Individuals with pre-existing major depressive disorder appeared significantly more likely than those without it to die of their cancer within 1 year or 5 years; however, receipt of psychotherapy within 4 weeks of cancer diagnosis considerably reduced that risk, an analysis of Medicare data presented at American Society for Radiation Oncology Annual Meeting showed.
“These findings emphasize the importance of early recognition, and